North America Allergy Diagnostics Market (2026-2031)
The North America Allergy Diagnostics Market was valued at $1705.2 Million in 2026 and projected to reach to $2797.3 Million by 2031, representing a compound annual growth rate of CAGR 10.4%. North America's allergy diagnostics market is positioned for sustained growth, driven by escalating prevalence of allergic diseases, heightened consumer awareness, and continuous technological advancements in diagnostic methodologies.
North America Allergy Diagnostics Market Trends and Insights
- Asia Pacific's growth trajectory reflects rising prevalence of allergic diseases, increasing healthcare spending, and expanding diagnostic infrastructure across the region.
- The 10.4% compound annual growth rate in Asia Pacific significantly outpaces many mature markets, driven by growing awareness of allergy testing and improved access to advanced diagnostic technologies. Asia Pacific's allergy diagnostics sector benefits from demographic shifts, urbanization, and environmental factors that elevate allergy incidence across the region.
- Key markets within Asia Pacific, including China, India, Japan, and Southeast Asia, are investing heavily in healthcare modernization and diagnostic capabilities.
- Between 2026 and 2031, Asia Pacific is expected to capture increasing market share as healthcare providers adopt immunoassay platforms, molecular diagnostics, and point-of-care testing solutions tailored to regional needs..
Key Market Statistics
- CAGR (2026-2031) CAGR 10.4%
- Market Size, 2026 ~USD 1705.2 Million
- Forecast, 2031 ~USD 2797.3 Million
- Geography North America
North America Allergy Diagnostics Market Overview
Dominant US Market Leadership :
The United States commands the North American allergy diagnostics market with a valuation of USD 2,025.8 million, representing the largest regional contributor and driving innovation in diagnostic technologies and clinical adoption.
Strong Regional Growth Trajectory :
North America's allergy diagnostics market is expanding at a 10.4% CAGR, outpacing the global average of 9.6%, driven by high healthcare spending, advanced diagnostic infrastructure, and increasing allergy prevalence across the region.
Canada's Emerging Contribution :
Canada represents a significant secondary market within North America at USD 306.8 million, supported by robust healthcare systems, rising allergic disease awareness, and increasing investment in diagnostic capabilities.
Projected Market Expansion :
The North American market is forecasted to grow from USD 1,705.2 million in 2026 to USD 2,797.3 million by 2031, reflecting sustained demand for advanced allergy testing solutions and improved patient access to diagnostic services.
North America Allergy Diagnostics Market Dynamics
- The region benefits from well-established healthcare infrastructure, significant R&D investments, and favorable reimbursement policies that facilitate market penetration and adoption of innovative testing solutions. The forecast period through 2031 anticipates accelerated expansion as healthcare providers increasingly integrate advanced allergy diagnostics into clinical practice.
- Rising healthcare expenditures, growing demand for personalized medicine, and expanding diagnostic laboratory networks across the US and Canada will further propel market growth, positioning North America as a key revenue generator in the global allergy diagnostics landscape..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Key Takeaways
- Asia Pacific allergy diagnostics market grows from $1,705.2M (2026) to $2,797.3M (2031) at 10.4% CAGR
- Rising allergy prevalence and healthcare modernization drive Asia Pacific market expansion
- Asia Pacific adoption of advanced diagnostic technologies accelerates between 2026 and 2031
- Key Asia Pacific markets including China, India, and Japan lead regional growth momentum
Allergy Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | IN VITRO TESTS (Test Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 9.6% from 2026 to 2031 |
| Largest Segment | CONSUMABLES (Product & Service) |
| Market Size Base Year (Billions) | ~USD 6.81 (2026) |
| Revenue Forecast (Billions) | ~USD 10.77 (2031) |
| Segments Covered | Product & Service, Type, Test Type, Allergen, End User |
North America Allergy Diagnostics Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product & Service
- Consumables
- Instruments
- Services
By Type
- Immunoassay Analyzers
- Luminometers
- Other In Vivo Tests
- Other Instruments
- Patch Tests
- Skin Prick Tests
By Test Type
- In Vitro Tests
- In Vivo Tests
By Allergen
- Drug Allergens
- Food Allergens
- Inhaled Allergens
- Other Allergens
By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Hospital-Based Laboratories
- Other End Users
Target Audience
- Diagnostic Device Manufacturers : Manufacturers need North America-specific market data to develop competitive allergy diagnostic products, optimize distribution channels, and identify growth opportunities in the US and Canadian markets.
- Healthcare Providers & Laboratories : Clinical laboratories and healthcare systems require market insights to justify investments in allergy diagnostic infrastructure, benchmark performance against regional standards, and enhance service offerings.
- Investment & Private Equity Firms : Investors evaluating opportunities in North American healthcare diagnostics need detailed market sizing, growth projections, and competitive analysis to assess portfolio companies and acquisition targets.
- Pharmaceutical & Biotech Companies : Companies developing allergy treatments and therapeutics require market intelligence on diagnostic adoption rates and patient populations in North America to inform clinical trial design and commercialization strategies.
- Healthcare Consultants & Analysts : Consultants advising healthcare organizations need comprehensive North American market data to support strategic planning, market entry analysis, and competitive positioning recommendations.
Key Companies in the North America Allergy Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| TECAN GROUP LTD. | Switzerland |
TECAN GROUP LTD.
TECAN GROUP LTD. is a Swiss life sciences company providing laboratory automation and diagnostic instruments.
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 2025.8 Million |
| Canada | USD 306.8 Million |
Country market size visualization
Reasons to Buy this Report
- Market Size & Growth Validation : Access precise market valuations for North America (USD 1,705.2M in 2026) with country-level breakdowns for the US and Canada, enabling accurate financial forecasting and investment decision-making.
- Competitive Landscape Intelligence : Understand market dynamics specific to North America's 10.4% CAGR growth, identifying opportunities to capture market share in the fastest-growing diagnostic segment within the region.
- Country-Specific Strategic Planning : Leverage detailed insights into US (USD 2,025.8M) and Canadian (USD 306.8M) markets to tailor product development, pricing strategies, and market entry approaches for each North American country.
- Forecast-Driven Business Strategy : Utilize 2031 projections (USD 2,797.3M) to align long-term business objectives, resource allocation, and expansion plans with anticipated market growth trajectories in North America.
- Regulatory & Reimbursement Insights : Gain region-specific understanding of North American healthcare policies, reimbursement frameworks, and regulatory requirements that influence allergy diagnostics adoption and market accessibility.
Frequently asked questions
What is the projected size of the Asia Pacific allergy diagnostics market in 2031?
The Asia Pacific allergy diagnostics market is projected to reach USD 2,797.3 million by 2031, growing from USD 1,705.2 million in 2026.
What is the CAGR for Asia Pacific allergy diagnostics market?
Asia Pacific allergy diagnostics market is expected to grow at a compound annual growth rate (CAGR) of 10.4% from 2026 to 2031.
Which countries in Asia Pacific are driving allergy diagnostics growth?
Key Asia Pacific markets including China, India, Japan, and Southeast Asian nations are driving growth through healthcare investments and rising allergy awareness.
What factors are accelerating Asia Pacific allergy diagnostics adoption?
Urbanization, environmental factors, increasing allergy prevalence, healthcare modernization, and improved access to diagnostic technologies are accelerating adoption across Asia Pacific.
How does Asia Pacific allergy diagnostics growth compare to global trends?
Asia Pacific's 10.4% CAGR outpaces the global allergy diagnostics market CAGR of 9.6%, reflecting stronger regional growth momentum.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the global Allergy Diagnostic market. Exhaustive secondary research was done to collect information on the allergy diagnostic market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market sizes of the allergy diagnostic market's segments and subsegments.
Secondary Research
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ in-house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the allergy diagnostic market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, VPs/managing directors, marketing heads/directors and sales directors, marketing/sales managers, regional/area sales managers, export/import heads/managers, and other market-related personnel from various companies and organizations operating in the allergy diagnostic market. Primary sources from the demand side included vice presidents in hospitals & clinics, C-level executives, department heads, doctors/physicians, hospital supply management teams, clinic personnel, and laboratory technicians.
Breakdown of Primary Interviews
Note 1: C-level primaries include CEOs, COOs, and CTOs.
Note 2: Others include sales managers, marketing managers, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3 = <USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the allergy diagnostic market. These methods were also widely used to estimate the sizes of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The market was divided into four segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the market engineering process and arrive at precise statistics for all segments.
Approach to derive the market size and estimate market growth: Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of allergy diagnostic products. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
Allergy testing helps determine the substances causing a patient's allergy symptoms. Tests include skin tests, intradermal tests, challenge tests, blood tests, and patch tests. Allergists commonly conduct challenge tests, including food, inhalation, drug, and physical challenges. Blood tests are generally used when unsafe or unapplicable skin tests are required, such as when consuming certain medications or having a skin condition that may interfere with skin testing. Allergy tests, such as in vitro & in vivo tests, are performed to determine the cause, stage, prognosis, and treatment course for allergic diseases.
Key Stakeholders
- Allergy Diagnostic Reagents, Kits, and Instrument Manufacturers
- Allergy Diagnostic Vendors and Distributors
- Hospitals
- Diagnostic Laboratories
- Allergy Diagnostic Service Providers
- Academic Research Institutes
- Venture Capitalists and Investors
- Contract Research Organizations (CROs)
Report Objectives
- To describe, analyze, and forecast the allergy diagnostic market, by product & service, test type, allergen, end user, and region
- To describe and forecast the allergy diagnostic market for key regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries
- To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing the growth of the allergy diagnostic market
- To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s Five Forces, and prices pertaining to the market under study
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies in the allergy diagnostic market
- To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the allergy diagnostic market
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific allergy diagnostic market into Vietnam, New Zealand, and others
- Further breakdown of the Rest of Latin America allergy diagnostic market into Colombia, Chile, Ecuador, and others
- Further breakdown of the Rest of Europe allergy diagnostic market into Belgium, Russia, the Netherlands, Switzerland, and others
Get the Full Allergy Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Allergy Diagnostics Market.
- Canada Allergy Diagnostics Market
- US Allergy Diagnostics Market
- Germany Allergy Diagnostics Market
- UK Allergy Diagnostics Market
- France Allergy Diagnostics Market
- Italy Allergy Diagnostics Market
- Spain Allergy Diagnostics Market
- China Allergy Diagnostics Market
- Japan Allergy Diagnostics Market
- India Allergy Diagnostics Market
- South Korea Allergy Diagnostics Market
- Australia Allergy Diagnostics Market
- Brazil Allergy Diagnostics Market
- Mexico Allergy Diagnostics Market
- GCC Countries Allergy Diagnostics Market
- Rest Of Europe Allergy Diagnostics Market
- Rest Of Asia Pacific Allergy Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report